Feliksas Jankevičius

Considerations on implementing diagnostic markers into clinical decision making in bladder cancer

Yair Lotan, Shahrokh F. Shariat, Bernd J. Schmitz‐Dräger et al. · Urologic Oncology Seminars and Original Investigations · 2010 · 106 citations

Medicine, Oncology, Urology +16

The utility of urine-circulating miRNAs for detection of prostate cancer

Kristina Stuopelytė, Kristina Daniūnaitė, Arnas Bakavičius et al. · British Journal of Cancer · 2016 · 104 citations · Full text

Medicine, Oncology, Urology +17

Frequent down-regulation of ABC transporter genes in prostate cancer

Rita Demidenko, Deividas Razanauskas, Kristina Daniūnaitė et al. · BMC Cancer · 2015 · 83 citations · Full text

Medicine, Genetics, Molecular Biology +17

Phase II study of MTX-HSA in combination with Cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma

Claus Bolling, T. Graefe, C. Lübbing et al. · Investigational New Drugs · 2006 · 77 citations

Medicine, Oncology, Pharmacology +11

Promoter Hypermethylation in Tumour Suppressor Genes Shows Association with Stage, Grade and Invasiveness of Bladder Cancer

Sonata Jarmalaitė, Feliksas Jankevičius, Kristina Kurgonaite et al. · Oncology · 2008 · 61 citations

Medicine, Oncology, Urology +17